Department of Microbiology and Biochemical Pharmacy, National Engineering Research Centre of Immunological Products, College of Pharmacy, Third Military Medical University, Chongqing, China.
La Trobe Institute of Molecular Science, La Trobe University, Bundoora, Victoria, Australia.
FASEB J. 2019 Apr;33(4):5018-5033. doi: 10.1096/fj.201802016RR. Epub 2018 Dec 31.
Cathepsin C (CtsC) functions as a central coordinator for activation of many serine proteases in immune cells. However, CtsC expression in gastric epithelial cells and its role in Helicobacter pylori infection remain unclear. Real-time PCR, Western blot, and immunohistochemistry analyses identified that CtsC was decreased in gastric mucosa of H. pylori-infected patients and mice. Isolated gastric epithelial cells and cell lines were stimulated with H. pylori and/or TGF-β1 showed that down-regulation of CtsC in gastric epithelial cells largely depended on H. pylori cagA via Src/ERK and Janus kinase (JAK)/signal transducer and activator of transcription 3 (STAT3) pathways, and the effect could be synergistically augmented by TGF-β1 in an autocrine manner. In human gastric mucosa, CtsC expression was negatively correlated with bacteria colonization; accordingly, provision of exogenous active CtsC overwhelmed H. pylori persistence in gastric mucosa of mice. In the presence of active CtsC, isolated human neutrophils activated via NF-κB pathway with augmented bactericidal capacity in vitro. We also found that neutrophils activated and cleared bacteria in active CtsC-injected mice and that there was no bactericidal capacity in mice that were simultaneously neutrophil-depleted by Ly6G antibody. Our findings identified a mechanism that H. pylori abrogate CtsC to impair neutrophil activation and to ensure persistence in gastric mucosa. Efforts to enable and boost this neutrophil activation pathway by active CtsC may therefore become valuable strategies in treating H. pylori infection.-Liu, Y. G., Teng, Y. S., Cheng, P., Kong, H., Lv, Y. P., Mao, F. Y., Wu, X. L., Hao, C. J., Chen, W., Yang, S. M., Zhang, J. Y., Peng, L. S., Wang, T. T., Han, B., Ma, Q., Zou, Q. M., Zhuang, Y. Abrogation of cathepsin C by Helicobacter pylori impairs neutrophil activation to promote gastric infection.
组织蛋白酶 C(CtsC)作为免疫细胞中许多丝氨酸蛋白酶激活的中心协调因子发挥作用。然而,CtsC 在胃上皮细胞中的表达及其在幽门螺杆菌感染中的作用尚不清楚。实时 PCR、Western blot 和免疫组织化学分析鉴定出 CtsC 在幽门螺杆菌感染患者和小鼠的胃黏膜中减少。用幽门螺杆菌和/或 TGF-β1 刺激分离的胃上皮细胞和细胞系表明,胃上皮细胞中 CtsC 的下调在很大程度上取决于幽门螺杆菌 cagA 通过Src/ERK 和 Janus 激酶(JAK)/信号转导和转录激活因子 3(STAT3)途径,并且该效应可以通过自分泌方式协同增强 TGF-β1。在人胃黏膜中,CtsC 的表达与细菌定植呈负相关;因此,提供外源性活性 CtsC 可克服幽门螺杆菌在小鼠胃黏膜中的持续存在。在存在活性 CtsC 的情况下,通过 NF-κB 途径激活的分离人嗜中性粒细胞在体外具有增强的杀菌能力。我们还发现,在注射活性 CtsC 的小鼠中,嗜中性粒细胞被激活并清除了细菌,并且在同时用 Ly6G 抗体耗尽嗜中性粒细胞的小鼠中没有杀菌能力。我们的研究结果确定了一种机制,即幽门螺杆菌破坏 CtsC 以损害嗜中性粒细胞的激活并确保其在胃黏膜中的持续存在。通过活性 CtsC 启用和增强这种嗜中性粒细胞激活途径的努力可能成为治疗幽门螺杆菌感染的有价值策略。-刘,Y. G.,滕,Y. S.,程,P.,孔,H.,吕,Y. P.,毛,F. Y.,吴,X. L.,郝,C. J.,陈,W.,杨,S. M.,张,J. Y.,彭,L. S.,王,T. T.,韩,B.,马,Q.,邹,Q. M.,庄,Y. 幽门螺杆菌对组织蛋白酶 C 的破坏削弱了嗜中性粒细胞的激活,促进了胃感染。